LOS ANGELES, Jan. 13, 2011 /PRNewswire/ -- UBM Canon and IVD Technology  are proud to add a new webinar to its webcast series on The Fundamentals of In Vitro Diagnostics. This one-hour event will focus specifically on Advanced Assay Technologies and Development Methods  and will offer an in-depth analysis and discussion from experts in the industry.
Various market reports and studies have concluded that the future for immunoassays is a mixed bag. In the clinical laboratory, mature assays will show moderate growth while emerging assays  will fuel most of the growth in this IVD segment. However, all immunoassays  will have to pass the test of medical research to demonstrate their contributions to improving patient outcomes. In this webinar event, attendees will learn more about how immunoassays, combined with DNA probe studies, will have an important place in post-genomic  medicine.
This Webcast will feature presentations by Neal Siegel, PhD, Chief Scientific Officer, Sword Diagnostics; Scott Dylewski, PhD, Senior Scientist, Alverix Inc.; and Nick Gee, PhD, CEO/CSO, Innova Biosciences Ltd. The Webcast concludes with a live Q&A session moderated by Richard Park, Editor-in-Chief of IVD Technology magazine. For more information on our speakers,